High Tech Pharm Co Ltd
KOSDAQ:106190
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
High Tech Pharm Co Ltd
KOSDAQ:106190
|
KR |
Intrinsic Value
The intrinsic value of High Tech Pharm Co Ltd (106190) under the Base Case is 12 624.14 KRW per share. Compared with the current market price of 9 120 KRW, the stock appears Undervalued by 28% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What High Tech Pharm Does
High Tech Pharm is a South Korean pharmaceutical company that makes and sells medicines and related healthcare products. Its business is centered on developing, manufacturing, and supplying drug products that are sold through pharmacies, hospitals, and other medical channels. In plain terms, it sits in the middle of the drug supply chain: it turns pharmaceutical ingredients and formulations into finished products that doctors, pharmacists, and patients can use.
- Headquarters
- Korea KR
- Employees
- 99
- IPO date
- Jul 28, 2010
Revenue & Expenses Breakdown
High Tech Pharm Co Ltd
Earnings Waterfall
High Tech Pharm Co Ltd
The intrinsic value for High Tech Pharm Co Ltd (106190) under the Base Case is 12 624.14 KRW.
Compared with the current market price of 9 120 KRW, the stock appears Undervalued by 28% .